Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults
MBAT
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
Insomnia can be a chronic problem that leads to significant daytime fatigue, stress and numerous negative health consequences including depression. Advanced Medical Electronics, in partnership with researchers are the University of Pennsylvania, propose developing an innovative, non-drug, low-risk, intervention that can be implemented on mobile devices for the treatment of insomnia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 27, 2017
CompletedFirst Posted
Study publicly available on registry
March 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2017
CompletedJuly 18, 2017
July 1, 2017
10 months
February 27, 2017
July 13, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Sleep onset latency
Time to fall asleep
two weeks
Study Arms (1)
MBAT
EXPERIMENTALMonitored breathing awareness therapy administered using a mobile device on a nightly basis during sleep onset.
Interventions
Eligibility Criteria
You may qualify if:
- \) Sleep onset latency \> 30 min for at least 3 nights per week
You may not qualify if:
- Unable to perform tests due to inability to communicate verbally/blindness, inability to write and read in English (the study questionnaires are in English and do not exist in validated form for other languages).
- Cognitive impairment; cognitively impaired patients may not be able to comply with the protocol).
- History of a diagnosed non-insomnia sleep disorder, such as sleep apnea or circadian rhythm disorder
- Upper extremity motor impairment that would preclude MBAT therapy (e.g., quadriplegia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Advanced Medical Electronicscollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 27, 2017
First Posted
March 7, 2017
Study Start
July 1, 2016
Primary Completion
April 30, 2017
Study Completion
April 30, 2017
Last Updated
July 18, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will share
At conclusion of study as per NIH guidelines